Document 0258
 DOCN  M9440258
 TI    Serologic testing for sexually transmitted diseases.
 DT    9404
 AU    Thomas DL; Quinn TC; Division of Infectious Diseases, Johns Hopkins
       University School; of Medicine, Baltimore, Maryland.
 SO    Infect Dis Clin North Am. 1993 Dec;7(4):793-824. Unique Identifier :
       AIDSLINE MED/94149264
 AB    This article addresses current issues regarding serologic testing for
       selected STDs, particularly those for which serologic testing has been
       useful for diagnosis, monitoring therapy, or seroepidemiology. For each
       selected pathogen, the authors discuss the strengths and weaknesses of
       the serologic tests as diagnostic assays, as measures of disease
       incidence and relevance, and as prospective markers identifying risk
       alterations in a given population. Also, for some conditions such as
       syphilis, the usefulness of serology as a measure of therapy or success
       of disease intervention is briefly outlined.
 DE    Chancroid/DIAGNOSIS/EPIDEMIOLOGY  Chlamydia
       Infections/DIAGNOSIS/EPIDEMIOLOGY  Female  Hepatitis, Viral,
       Human/DIAGNOSIS/EPIDEMIOLOGY  Herpes Simplex/DIAGNOSIS/EPIDEMIOLOGY
       Human  HIV Infections/DIAGNOSIS/EPIDEMIOLOGY  Male  Serodiagnosis
       Sexually Transmitted Diseases/*DIAGNOSIS/EPIDEMIOLOGY
       Syphilis/EPIDEMIOLOGY  Syphilis Serodiagnosis  United
       States/EPIDEMIOLOGY  JOURNAL ARTICLE  REVIEW  REVIEW, ACADEMIC

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).